Use of the CHA(2)DS(2)-VASc and HAS-BLED scores to aid decision making for thromboprophylaxis in nonvalvular atrial fibrillation

Circulation. 2012 Aug 14;126(7):860-5. doi: 10.1161/CIRCULATIONAHA.111.060061.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Anticoagulants / therapeutic use
  • Aspirin / therapeutic use
  • Atrial Fibrillation / diagnosis*
  • Atrial Fibrillation / drug therapy*
  • Decision Making*
  • Female
  • Fibrinolytic Agents / therapeutic use
  • Hemorrhage / chemically induced
  • Humans
  • Patient Preference
  • Platelet Aggregation Inhibitors / therapeutic use
  • Practice Guidelines as Topic
  • Severity of Illness Index
  • Sex Factors
  • Stroke / prevention & control
  • Thrombosis / prevention & control*
  • Treatment Outcome

Substances

  • Anticoagulants
  • Fibrinolytic Agents
  • Platelet Aggregation Inhibitors
  • Aspirin